Antibody Molecular Structure

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Volumn , Issue , 2009, Pages 51-66

  Stanfield, Robyn L ^a   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antibody molecular structure; Fab conformational changes; Human anti HIV 1 antibodies

Indexed keywords

EID: 84890996033     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470485408.ch2     Document Type: Chapter

References (59)

1. Al-Lazikani, B., A.M. Lesk, and C. Chothia. 1997. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273:927-948.
2. Arbabi Ghahroudi, M., A. Desmyter, L. Wyns, R. Hamers, and S. Muyldermans. 1997. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414:521-526.
3. Arevalo, J.H., C.A. Hassig, E.A. Stura, M.J. Sims, M.J. Taussig, and I.A. Wilson. 1994. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J. Mol. Biol. 241:663-690.
4. Arevalo, J.H., E.A. Stura, M.J. Taussig, and I.A. Wilson. 1993. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J. Mol. Biol. 231:103-118.
5. Arevalo, J.H., M.J. Taussig, and I.A. Wilson. 1993. Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature 365:859-863.
6. Better, M., C.P. Chang, R.R. Robinson, and A.H. Horwitz. 1988. Escherichia coli secretion of an active chimeric antibody fragment. Science 240:1041-1043.
7. Blixt, O., S. Head, T. Mondala, C. Scanlan, M.E. Huflejt, R. Alvarez, M.C. Bryan, F. Fazio, D. Calarese, J. Stevens, N. Razi, D.J. Stevens, J.J. Skehel, I. van Die, D.R. Burton, I.A. Wilson, R. Cummings, N. Bovin, C.H. Wong, and J.C. Paulson. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101:17033-17038.
8. Bork, P., L. Holm, and C. Sander. 1994. The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242:309-320.
9. Boulianne, G.L., N. Hozumi, and M.J. Shulman. 1984. Production of functional chimaeric mouse/human antibody. Nature 312:643-646.
10. Bryan, M.C., F. Fazio, H.K. Lee, C.Y. Huang, A. Chang, M.D. Best, D.A. Calarese, O. Blixt, J.C. Paulson, D. Burton, I.A. Wilson, and C.H. Wong. 2004. Covalent display of oligosaccharide arrays in microtiter plates. J. Am. Chem. Soc. 126:8640-8641.
11. Burton, D.R., R.L. Stanfield, and I.A. Wilson. 2005. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA 102:14943-14948.
12. Calarese, D.A., H.K. Lee, C.Y. Huang, M.D. Best, R.D. Astronomo, R.L. Stanfield, H. Katinger, D.R. Burton, C.H. Wong, and I.A. Wilson. 2005. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc. Natl. Acad. Sci. USA 102:13372-13377.
13. Calarese, D.A., C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, K.H. Roux, J.W. Kelly, P.M. Rudd, R.A. Dwek, H. Katinger, D.R. Burton, and I.A. Wilson. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
14. Cardoso, R.M., F.M. Brunel, S. Ferguson, M. Zwick, D.R. Burton, P.E. Dawson, and I.A. Wilson. 2007. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J. Mol. Biol. 365:1533-1544.
15. Cardoso, R.M., M.B. Zwick, R.L. Stanfield, R. Kunert, J.M. Binley, H. Katinger, D.R. Burton, and I.A. Wilson. 2005. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22:163-173.
16. Choe, H., W. Li, P.L. Wright, N. Vasilieva, M. Venturi, C.C. Huang, C. Grundner, T. Dorfman, M.B. Zwick, L. Wang, E.S. Rosenberg, P.D. Kwong, D.R. Burton, J.E. Robinson, J.G. Sodroski, and M. Farzan. 2003. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114:161-170.
17. Chothia, C., and A.M. Lesk. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196:901-917.
18. Cole, S.P., B.G. Campling, T. Atlaw, D. Kozbor, and J.C. Roder. 1984. Human monoclonal antibodies. Mol. Cell Biochem. 62:109-120.
19. Collis, A.V., A.P. Brouwer, and A.C. Martin. 2003. Analysis of the antigen combining site: Correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. J. Mol. Biol. 325:337-354.
20. Darbha, R., S. Phogat, A.F. Labrijn, Y. Shu, Y. Gu, M. Andrykovitch, M.Y. Zhang, R. Pantophlet, L. Martin, C. Vita, D.R. Burton, D.S. Dimitrov, and X. Ji. 2004. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Biochemistry 43:1410-1417.
21. Davies, J., and L. Riechmann. 1996. Single antibody domains as small recognition units: Design and in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein Eng. 9:531-537.
22. Desmyter, A., T.R. Transue, M.A. Ghahroudi, M.H. Thi, F. Poortmans, R. Hamers, S. Muyldermans, and L. Wyns. 1996. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat. Struct. Biol. 3:803-811.
23. Dooley, H., M.F. Flajnik, and A.J. Porter. 2003. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display. Mol. Immunol. 40:25-33.
24. Foote, J., and C. Milstein. 1994. Conformational isomerism and the diversity of antibodies. Proc. Natl. Acad. Sci. USA 91:10370-10374.
25. Halaby, D.M., A. Poupon, and J. Mornon. 1999. The immunoglobulin fold family: Sequence analysis and 3D structure comparisons. Protein Eng. 12:563-571.
26. Harris, L.J., S.B. Larson, K.W. Hasel, J. Day, A. Greenwood, and A. McPherson. 1992. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature 360:369-372.
27. Harris, L.J., S.B. Larson, K.W. Hasel, and A. McPherson. 1997. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36:1581-1597.
28. Huang, C.C., S.N. Lam, P. Acharya, M. Tang, S.H. Xiang, S.S. Hussan, R.L. Stanfield, J. Robinson, J. Sodroski, I.A. Wilson, R. Wyatt, C.A. Bewley, and P.D. Kwong. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:1930-1934.
29. Huang, C.C., M. Tang, M.Y. Zhang, S. Majeed, E. Montabana, R.L. Stanfield, D.S. Dimitrov, B. Korber, J. Sodroski, I.A. Wilson, R. Wyatt, and P.D. Kwong. 2005. Structure of a V3-containing HIV-1 gp120 core. Science 310:1025-1028.
30. Huang, C.C., M. Venturi, S. Majeed, M.J. Moore, S. Phogat, M.Y. Zhang, D.S. Dimitrov, W.A. Hendrickson, J. Robinson, J. Sodroski, R. Wyatt, H. Choe, M. Farzan, and P.D. Kwong. 2004. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. USA 101:2706-2711.
31. Huse, W.D., L. Sastry, S.A. Iverson, A.S. Kang, M. Alting-Mees, D.R. Burton, S.J. Benkovic, and R.A. Lerner. 1989. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246:1275-1281.
32. James, L.C., P. Roversi, and D.S. Tawfik. 2003. Antibody multispecificity mediated by conformational diversity. Science 299:1362-1367.
33. Jones, P.T., P.H. Dear, J. Foote, M.S. Neuberger, and G. Winter. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522-525.
34. Kabat, E.A., and T.T. Wu. 1971. Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann. NYAcad. Sci. 190:382-393.
35. Koliasnikov, O.V., M.O. Kiral, V.G. Grigorenko, and A.M. Egorov. 2006. Antibody CDR H3 modeling rules: Extension for the case of absence of Arg H94 and Asp H101. J. Bioinform. Comput. Biol. 4:415-424.
36. Morrison, S.L., M.J. Johnson, L.A. Herzenberg, and V.T. Oi. 1984. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81:6851-6855.
37. Neuberger, M.S., G.T. Williams, E.B. Mitchell, S.S. Jouhal, J.G. Flanagan, and T.H. Rabbitts. 1985. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314:268-270.
38. Ofek, G., M. Tang, A. Sambor, H. Katinger, J.R. Mascola, R. Wyatt, and P.D. Kwong. 2004. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78:10724-10737.
39. Padlan, E.A., D.M. Segal, T.F. Spande, D.R. Davies, S. Rudikoff, and M. Potter. 1973. Structure at 4.5 A resolution of a phosphorylcholine-binding Fab. Nat. New Biol. 245:165-167.
40. Rini, J.M., R.L. Stanfield, E.A. Stura, P.A. Salinas, A.T. Profy, and I.A. Wilson. 1993. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. USA 90:6325-6329.
41. Roux, K.H., L. Strelets, and T.E. Michaelsen. 1997. Flexibility of human IgG subclasses. J. Immunol. 159: 3372-3382.
42. Roux, K.H., P. Zhu, M. Seavy, H. Katinger, R. Kunert, and V. Seamon. 2004. Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12. Mol. Immunol. 41:1001-1011.
43. Sanders, R.W., M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K.O. Lloyd, P.D. Kwong, and J.P. Moore. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
44. Saphire, E.O., P.W. Parren, R. Pantophlet, M.B. Zwick, G.M. Morris, P.M. Rudd, R.A. Dwek, R.L. Stanfield, D.R. Burton, and I.A. Wilson. 2001. Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design. Science 293:1155-1159.
45. Scanlan, C.N., R. Pantophlet, M.R. Wormald, E. Ollmann Saphire, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, P.M. Rudd, and D.R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
46. Segal, D.M., E.A. Padlan, G.H. Cohen, S. Rudikoff, M. Potter, and D.R. Davies. 1974. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA 71:4298-4302.
47. Shirai, H., A. Kidera, and H. Nakamura. 1996. Structural classification of CDR-H3 in antibodies. FEBS Lett. 399:1-8.
48. Skerra, A., and A. Pluckthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038-1041.
49. Spinelli, S., L. Frenken, D. Bourgeois, L. de Ron, W. Bos, T. Verrips, C. Anguille, C. Cambillau, and M. Tegoni. 1996. The crystal structure of a llama heavy chain variable domain. Nat. Struct. Biol. 3:752-757.
50. Stanfield, R.L., H. Dooley, M.F. Flajnik, and I.A. Wilson. 2004. Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science 305:1770-1773.
51. Stanfield, R.L., H. Dooley, P. Verdino, M.F. Flajnik, and I.A. Wilson. 2007. Maturation of shark single-domain (IgNAR) antibodies: Evidence for induced-fit binding. J. Mol. Biol. 367:358-372.
52. Stanfield, R.L., M. Takimoto-Kamimura, J.M. Rini, A.T. Profy, and I.A. Wilson. 1993. Major antigen-induced domain rearrangements in an antibody. Structure 1:83-93.
53. Stanfield, R.L., and I.A. Wilson. 1994. Antigen-induced conformational changes in antibodies: A problem for structural prediction and design. Trends Biotechnol. 12:275-279.
54. Stanfield, R.L., A. Zemla, I.A. Wilson, and B. Rupp. 2006. Antibody elbow angles are influenced by their light chain class. J. Mol. Biol. 357:1566-1574.
55. Steinitz, M., G. Klein, S. Koskimies, and O. Makel. 1977. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 269:420-422.
56. Wilson, I.A., and R.L. Stanfield. 1994. Antibody-antigen interactions: New structures and new conformational changes. Curr. Opin. Struct. Biol. 4:857-867.
57. Wilson, I.A., R.L. Stanfield, J.M. Rini, J.H. Arevalo, U. Schulze-Gahmen, D.H. Fremont, and E.A. Stura. 1991. Structural aspects of antibodies and antibody-antigen complexes. Ciba Found. Symp. 159:13-28; discussion 28-39.
58. Wu, T.T., and E.A. Kabat. 1970. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132:211-250.
59. Zhou, T., L. Xu, B. Dey, A.J. Hessell, D. Van Ryk, S.H. Xiang, X. Yang, M.Y. Zhang, M.B. Zwick, J. Arthos, D.R. Burton, D.S. Dimitrov, J. Sodroski, R. Wyatt, G.J. Nabel, and P.D. Kwong. 2007. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445:732-737.